Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Fuji
Mallinckrodt
Teva
Healthtrust
McKinsey
Covington
Daiichi Sankyo
Johnson and Johnson
Fish and Richardson

Generated: February 19, 2018

DrugPatentWatch Database Preview

VEETIDS '250' Drug Profile

« Back to Dashboard

Which patents cover Veetids '250', and what generic alternatives are available?

Veetids '250' is a drug marketed by Apothecon and is included in four NDAs.

The generic ingredient in VEETIDS '250' is penicillin v potassium. There are eighty-nine drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.

US Patents and Regulatory Information for VEETIDS '250'

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon VEETIDS '250' penicillin v potassium FOR SOLUTION;ORAL 061206-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apothecon VEETIDS '250' penicillin v potassium TABLET;ORAL 062156-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apothecon VEETIDS '250' penicillin v potassium FOR SOLUTION;ORAL 062153-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apothecon VEETIDS '250' penicillin v potassium TABLET;ORAL 061164-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Argus Health
Medtronic
Merck
Dow
Teva
Accenture
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot